Cyclic Nucleotide Phosphodiesterases, Type 2
"Cyclic Nucleotide Phosphodiesterases, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic nucleotide phosphodiesterase subfamily that is activated by the binding of CYCLIC GMP to an allosteric domain found on the enzyme. Multiple enzyme variants of this subtype can be produced due to multiple alternative mRNA splicing. The subfamily is expressed in a broad variety of tissues and may play a role in mediating cross-talk between CYCLIC GMP and CYCLIC CMP pathways. Although the type 2 enzymes are classified as 3',5'-cyclic-AMP phosphodiesterases (EC 3.1.4.17), members of this class have additional specificity for CYCLIC GMP.
Descriptor ID |
D054678
|
MeSH Number(s) |
D08.811.277.352.640.150.200 D08.811.277.352.640.155.200 D12.644.360.008.200 D12.644.360.009.200 D12.776.476.008.200 D12.776.476.009.200
|
Concept/Terms |
Cyclic Nucleotide Phosphodiesterases, Type 2- Cyclic Nucleotide Phosphodiesterases, Type 2
- Cyclic GMP-Stimulated Phosphodiesterase
- Cyclic GMP Stimulated Phosphodiesterase
- Phosphodiesterase, Cyclic GMP-Stimulated
- Cyclic Nucleotide Phosphodiesterase PDE2 Family
- PDE2 Phosphodiesterase
- PDE2 Phosphodiesterases
Cyclic Nucleotide Phosphodiesterases, Type 2A- Cyclic Nucleotide Phosphodiesterases, Type 2A
- cGMP-Dependent 3',5'-Cyclic Phosphodiesterase
- 3',5'-Cyclic Phosphodiesterase, cGMP-Dependent
- cGMP Dependent 3',5' Cyclic Phosphodiesterase
- Phosphodiesterase 2A
|
Below are MeSH descriptors whose meaning is more general than "Cyclic Nucleotide Phosphodiesterases, Type 2".
- Chemicals and Drugs [D]
- Enzymes and Coenzymes [D08]
- Enzymes [D08.811]
- Hydrolases [D08.811.277]
- Esterases [D08.811.277.352]
- Phosphoric Diester Hydrolases [D08.811.277.352.640]
- 3',5'-Cyclic-AMP Phosphodiesterases [D08.811.277.352.640.150]
- Cyclic Nucleotide Phosphodiesterases, Type 2 [D08.811.277.352.640.150.200]
- 3',5'-Cyclic-GMP Phosphodiesterases [D08.811.277.352.640.155]
- Cyclic Nucleotide Phosphodiesterases, Type 2 [D08.811.277.352.640.155.200]
- Amino Acids, Peptides, and Proteins [D12]
- Peptides [D12.644]
- Intracellular Signaling Peptides and Proteins [D12.644.360]
- 3',5'-Cyclic-AMP Phosphodiesterases [D12.644.360.008]
- Cyclic Nucleotide Phosphodiesterases, Type 2 [D12.644.360.008.200]
- 3',5'-Cyclic-GMP Phosphodiesterases [D12.644.360.009]
- Cyclic Nucleotide Phosphodiesterases, Type 2 [D12.644.360.009.200]
- Proteins [D12.776]
- Intracellular Signaling Peptides and Proteins [D12.776.476]
- 3',5'-Cyclic-AMP Phosphodiesterases [D12.776.476.008]
- Cyclic Nucleotide Phosphodiesterases, Type 2 [D12.776.476.008.200]
- 3',5'-Cyclic-GMP Phosphodiesterases [D12.776.476.009]
- Cyclic Nucleotide Phosphodiesterases, Type 2 [D12.776.476.009.200]
Below are MeSH descriptors whose meaning is more specific than "Cyclic Nucleotide Phosphodiesterases, Type 2".
This graph shows the total number of publications written about "Cyclic Nucleotide Phosphodiesterases, Type 2" by people in this website by year, and whether "Cyclic Nucleotide Phosphodiesterases, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclic Nucleotide Phosphodiesterases, Type 2" by people in Profiles.
-
Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress. Neurobiol Aging. 2015 Feb; 36(2):955-70.
-
Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway. Int J Neuropsychopharmacol. 2013 May; 16(4):835-47.
-
Grueneberg ganglion olfactory subsystem employs a cGMP signaling pathway. J Comp Neurol. 2009 Sep 01; 516(1):36-48.